Robin Shane Readnour

Companies

• AN2 Therapeutics, Inc.Board member Mar 24, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAN2 Therapeutics, Inc. ANTX633,842 shares²$2.1M at $3.27Sep 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 9, 2026Sold 585 shares at $6.02 of AN2 Therapeutics, Inc.²
• Sep 9, 2026Sold 523 shares at $6.02 of AN2 Therapeutics, Inc.²
• Sep 8, 2026Sold 5,294 shares at $6.02 of AN2 Therapeutics, Inc.³
• Sep 8, 2026Sold 4,725 shares at $6.02 of AN2 Therapeutics, Inc.³
• Sep 3, 2026Sold 3,223 shares at $6.07 of AN2 Therapeutics, Inc.³
• Sep 3, 2026Sold 2,877 shares at $6.07 of AN2 Therapeutics, Inc.³
• Aug 17, 2026Sold 18,706 shares at $6.01 of AN2 Therapeutics, Inc.⁴
• Aug 17, 2026Sold 16,696 shares at $6.01 of AN2 Therapeutics, Inc.⁴
• Dec 19, 2024Granted 9,077 shares of AN2 Therapeutics, Inc.⁵
• Dec 10, 2024Bought 5,000 shares at $1.49 of AN2 Therapeutics, Inc.⁶
• Dec 10, 2024Bought 5,000 shares at $1.49 of AN2 Therapeutics, Inc.⁶
• Dec 9, 2024Bought 18,483 shares at $1.43 of AN2 Therapeutics, Inc.⁶
• Dec 9, 2024Bought 12,289 shares at $1.43 of AN2 Therapeutics, Inc.⁶
• Dec 6, 2024Bought 6,517 shares at $1.45 of AN2 Therapeutics, Inc.⁶
• Dec 6, 2024Bought 12,711 shares at $1.45 of AN2 Therapeutics, Inc.⁶
• Nov 27, 2024Bought 25,000 shares at $1.42 of AN2 Therapeutics, Inc.⁷
• Nov 27, 2024Bought 25,000 shares at $1.42 of AN2 Therapeutics, Inc.⁷
• Nov 26, 2024Bought 12,500 shares at $1.39 of AN2 Therapeutics, Inc.⁷
• Nov 26, 2024Bought 12,500 shares at $1.39 of AN2 Therapeutics, Inc.⁷
• Nov 20, 2024Bought 25,000 shares at $1.15 of AN2 Therapeutics, Inc.⁸
• Nov 20, 2024Bought 25,000 shares at $1.16 of AN2 Therapeutics, Inc.⁸
• Nov 19, 2024Bought 75,000 shares at $1.04 of AN2 Therapeutics, Inc.⁸
• Nov 19, 2024Bought 75,000 shares at $1.03 of AN2 Therapeutics, Inc.⁸
• Jan 12, 2024Sold 719 shares at $21.91 of AN2 Therapeutics, Inc.⁹
• Jan 12, 2024Sold 706 shares at $21.92 of AN2 Therapeutics, Inc.⁹